Selection of a novel strain of Christensenella minuta as a future biotherapy for Crohn’s disease
Apr 11, 2022
more +YSOPIA Bioscience Announces the Appointment of Dr. Jean-Pierre Lehner as New Chairman of the Board...
Apr 8, 2022
more +YSOPIA Bioscience annonce la nomination du Dr. Jean-Pierre Lehner comme nouveau Président du...
Apr 8, 2022
more +Seventure Partners : Une croissance continue dans le secteur du microbiome en 2021 qui va se...
Mar 15, 2022
more +Species-targeted sorting and cultivation of commensal bacteria from the gut microbiome using flow...
Feb 16, 2022
more +